Coya Therapeutics stock surges as investors pump $10m into growth

Pallavi Madhiraju- October 22, 2024 0

Coya Therapeutics Inc. (NASDAQ: COYA) witnessed a 9% increase in its share value after securing $10 million through a private placement. The biotechnology firm, specializing ... Read More

Actinogen Medical makes bold A$11.1m move to boost Alzheimer’s drug trial

Pallavi Madhiraju- September 18, 2024 0

Actinogen Medical has raised 11.1 million AUD in a significant capital raise led by its CEO, Dr. Steven Gourlay, who personally invested 1 million AUD. ... Read More

FDA extends review period for Humacyte’s vascular trauma treatment ATEV

Pallavi Madhiraju- August 10, 2024 0

The U.S. Food and Drug Administration’s review of Humacyte, Inc.'s innovative vascular trauma treatment, known as the acellular tissue engineered vessel (ATEV), has hit an ... Read More

Recursion Pharmaceuticals and Exscientia announce merger to transform drug development

Pallavi Madhiraju- August 10, 2024 0

Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths to form a formidable entity in drug ... Read More

AbbVie acquires Celsius Therapeutics to enhance inflammatory disease treatment options

Pallavi Madhiraju- June 27, 2024 0

In a significant move within the biotechnology industry, AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, has completed the acquisition of Celsius Therapeutics, Inc., a ... Read More

MediLink Therapeutics, BioNTech expand partnership with new $1.8bn agreement

Pallavi Madhiraju- May 28, 2024 0

MediLink Therapeutics (Suzhou) Co., Ltd., a prominent clinical-stage biotech company, has entered into a significant new strategic collaboration with BioNTech SE, a leader in next-generation ... Read More

Innovent Biologics reports significant clinical success with picankibart in psoriasis treatment

Pallavi Madhiraju- May 28, 2024 0

Innovent Biologics, Inc. (HKEX: 01801) has announced remarkable results from the CLEAR-1 Phase 3 registrational study of its novel drug, picankibart (R & D code: ... Read More

Checkerspot and AAK forge alliance to revolutionize plant-based fats and oils sector

Pallavi Madhiraju- March 25, 2024 0

In a significant move towards sustainability and innovation, Checkerspot, Inc., a pioneering biotechnology company recognized for its renewable oils derived from microalgae fermentation, and AAK ... Read More

Merck announces over €300m investment in new bioprocessing center in South Korea

Pallavi Madhiraju- March 21, 2024 0

Merck has embarked on a monumental investment venture, injecting more than €300 million into the construction of a new Bioprocessing Production Center located in Daejeon, ... Read More

Balrampur Chini Mills spearheads India’s first bioplastics plant with global technological partnerships

Pallavi Madhiraju- March 17, 2024 0

In an unprecedented move toward sustainability, Balrampur Chini Mills Limited (BCML) has announced strategic agreements with three technology giants: Sulzer AG, Alpine Engineering GmbH, and ... Read More